scispace - formally typeset
I

Ihsan Gursel

Researcher at Bilkent University

Publications -  109
Citations -  9525

Ihsan Gursel is an academic researcher from Bilkent University. The author has contributed to research in topics: Immune system & CpG Oligodeoxynucleotide. The author has an hindex of 39, co-authored 103 publications receiving 7863 citations. Previous affiliations of Ihsan Gursel include University of London & Middle East Technical University.

Papers
More filters
Journal ArticleDOI

Biological properties of extracellular vesicles and their physiological functions

María Yáñez-Mó, +72 more
TL;DR: A comprehensive overview of the current understanding of the physiological roles of EVs is provided, drawing on the unique EV expertise of academia-based scientists, clinicians and industry based in 27 European countries, the United States and Australia.
Journal ArticleDOI

Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells

TL;DR: Findings indicate that hTLR9 plays a critical role in the CpG DNA-mediated activation of human cells and evolutionary divergence between TLR9 molecules underlies species-specific differences in the recognition of bacterial DNA.
Journal ArticleDOI

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

TL;DR: The high potential of nanosized EVs for both diagnostic and therapeutic areas of nanomedicine, as demonstrated by the European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD), is demonstrated.
Journal ArticleDOI

Use of CpG oligodeoxynucleotides as immune adjuvants

TL;DR: Synthetic oligodeoxynucleotides containing unmethylated CpG motifs directly stimulate human B cells and plasmacytoid dendritic cells, thereby promoting the production of T helper 1 and pro‐inflammatory cytokines and the maturation/activation of professional antigen‐presenting cells.
Journal ArticleDOI

Efficient production and enhanced tumor delivery of engineered extracellular vesicles.

TL;DR: The Scavenger Receptor Class A family (SR-A) is identified as a novel monocyte/macrophage uptake receptor for EV and blockade of SR-A with dextran sulfate dramatically decreased EV liver clearance in mice, while enhancing tumor accumulation.